AstraZeneca: Asthma trials

The registry lists 359 Asthma studies with AstraZeneca as lead sponsor. 19 are open to participants now and 129 have results posted.

Phase 1 46Phase 2 52Phase 3 123Phase 4 23No phase 117(a study in two phases counts in both)

Studies

Page 4 of 4. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Adult Asthmatics and Acid RefluxCompletedNCT00628953Phase 2
• Efficacy of Ciclesonide During the Cold Season in Patients Older Than 12 Years With Persistent AsthmaCompletedNCT00608218
• An Observational Study to Investigate How Patients Experience the Ability to Adjust Their Asthma Maintenance MedicationCompletedNCT00577265
• Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe AsthmaCompletedNCT00573222
• NIS for Patients Using Symbicort Turbuhaler for Maintenance and Reliever Therapy in a Single InhalerCompletedNCT00557297
• Effect of Inhaled Ciclesonide in Adult Patients With Asthma (BY9010/M1-125)CompletedNCT00546520Phase 3
• A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler®CompletedNCT00532922
• Asthma Control-A "Patient Follow up Programme" Maintenance and Reliever Therapy in a Single InhalerCompletedNCT00524641
• Symbicort SMART (Symbicort Maintenance And Reliever Therapy)CompletedNCT00523679
• Be SMART NIS, Moderate to Servere Asthma Patient ObservationCompletedNCT00514787
• A Sequential Dose-Escalation Study in Subjects With Mild AsthmaCompletedNCT00512486Phase 1
• A Follow-up Programme for Patients Using Symbicort SMART in Normal Clinical PracticeCompletedNCT00505388
• Open-label, Safety and Efficacy Study of Pulmicort® Turbuhaler® in Japanese Children With Bronchial AsthmaCompletedNCT00504062Phase 3
• A Pharmaceopidemiological Study in Patients Who Use Symbicort SMARTCompletedNCT00503061
• Safety and Efficacy Study of Eculizumab in Patients With Mild Allergic AsthmaCompletedNCT00485576Phase 2
• A Two-week Study Assessing the Onset of Effect Questionnaire (OEQ) Administered Daily Versus Weekly in Adult SubjectsCompletedNCT00449527Phase 3
• A Two-week Study Assessing the Onset of Effect Questionnaire Administered Pre-dose Versus Post-dose in Adult SubjectsCompletedNCT00449501Phase 3
• Prevention of Asthma Relapse After Discharge From EmergencyCompletedNCT00326053Phase 3
• Real Life Effectiveness in Asthma of Symbicort Single Inhaler TherapyCompletedNCT00319306Phase 3
• Safety and Tolerability of Ciclesonide and Formoterol Fumarate Inhaled Once Daily in Patients With Asthma (18 to 75 y) (BY9010/M1-506)CompletedNCT00314509Phase 2
• Effect of Ciclesonide on Quality of Life in Patients With Moderate Persistent Asthma (21 to 65 y) (BY9010/AR-101)CompletedNCT00305461Phase 3
• SALTO - Symbicort Single Inhaler Therapy Use in Adolescent Adults and Adults With Persistent AsthmaCompletedNCT00290264Phase 3
• SMILDA - Symbicort®Turbuhaler® Allergan Challenge Study in Allergic Patients With Mild AsthmaCompletedNCT00288379Phase 3
• Effect of Budesonide / Formoterol Combination in Repeated AMP ProvocationsCompletedNCT00272753Phase 4
• Improved Quality of the Treatment and Increased Compliance in Asthmatics Through the Dialog Tool Soren - Between Patient and CaregiverCompletedNCT00272727Not applicable
• SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and AdultsCompletedNCT00259792Phase 3
• SHARE - Symbicort and Health Economics in a Real Life EvaluationCompletedNCT00259766Phase 3
• Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With AsthmaCompletedNCT00255255Phase 3
• DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in AdultsCompletedNCT00252863Phase 3
• STYLE - Symbicort Single Inhaler Therapy vs Conventional Therapy in Treatment of Persistent AsthmaCompletedNCT00252824Phase 3
• Efficacy & Safety of Symbicort® TURBUHALER® 160/4.5 µg Twice Daily & Pulmicort® TURBUHALER® 200 µg Twice Daily + Theolong® Tablet 200 mg Twice Daily in Japanese Asthmatic PatientsCompletedNCT00252785Phase 3
• Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07).CompletedNCT00246922Phase 3
• A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler®CompletedNCT00244608Phase 3
• Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mgCompletedNCT00242775Phase 3
• MONO: Symbicort® Single Inhaler Therapy and Conventional Best Standard Treatment for the Treatment of Persistent Asthma in Adolescents and AdultsCompletedNCT00242411Phase 4
• Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05).CompletedNCT00242307Phase 2/3
• SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & AdultsCompletedNCT00238784Phase 3
• Symbicort Single Inhaler Therapy for Asthma in a General Practice SettingCompletedNCT00235911Phase 3
• PreAsthmaControl (PAC)CompletedNCT00234390Phase 4
• Pulmicort Asthma Prevention (Post-PAC)CompletedNCT00233584Not applicable
• Long Term Safety & Efficacy of Budesonide Inhalation Suspension in Japanese Children With Bronchial AsthmaCompletedNCT00232648Phase 3
• A Study to Assess the Concentration of Budesonide in Breast Milk From Asthmatic WomenCompletedNCT00228475Phase 4
• Trial to Compare the Safety, Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus in Children With AsthmaCompletedNCT00192257Phase 3
• Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013)CompletedNCT00163527Phase 3
• Efficacy and Safety of Roflumilast Taken in the Morning or Evening in Patients With Stable Asthma (12 to 70 y) (BY217/M2-015)CompletedNCT00163475Phase 3
• Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (6 to 11 y) (BY9010/M1-206)CompletedNCT00163462Phase 3
• Efficacy and Safety of Ciclesonide in Preschool Children With Asthma (2 to 6 Years) (BY9010/M1-207)CompletedNCT00163449Phase 3
• Efficacy and Safety of Ciclesonide Administered With or Without Different Spacers in Patients With Asthma (12 to 75 y) (BY9010/M1-145)CompletedNCT00163436Phase 3
• Efficacy of Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (12 to 75 y) (BY9010/M1-142)CompletedNCT00163423Phase 3
• Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (4 to 15 y) (BY9010/M1-205)CompletedNCT00163410Phase 3
• Efficacy of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-137)CompletedNCT00163397Phase 3
• Effectiveness of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-136)CompletedNCT00163384Phase 3
• Effects of Inhaled Ciclesonide Versus Fluticasone Propionate Versus Placebo on Lower Leg Growth in Prepubertal Children With Mild Persistent Asthma (6 to 12 y) (BY9010/M1-208)CompletedNCT00163371Phase 3
• Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132)CompletedNCT00163358Phase 3
• Efficacy of Ciclesonide on Small Airways in Patients With Stable Asthma (18 to 60 y) (BY9010/M1-131)CompletedNCT00163345Phase 3
• Effect of Inhaled Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (18 to 65 y) (BY9010/M1-129)CompletedNCT00163332Phase 3
• Efficacy of Ciclesonide and Fluticasone Propionate in Adult Patients With Moderate and Severe Persistent Asthma (18 to 75 y) (BY9010/IT-101)CompletedNCT00163319Phase 3
• The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)CompletedNCT00076076Phase 3
• Efficacy and Safety of Roflumilast in Patients With Asthma (BY217/M2-012)CompletedNCT00073177Phase 3